Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 10, 2017 08:00 ET | Source: Aevi Genomic Medicine, Inc.

Aevi Genomic Medicine Announces Plans to Initiate Phase 2 Clinical Trial to Confirm Genetic Responders to AEVI-001 and First Quarter 2017 Operating Results

PHILADELPHIA, PA--(Marketwired - May 10, 2017) - Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) Company to initiate a Phase 2 clinical trial in 2H 2017, targeting a...
May 03, 2017 08:00 ET | Source: Aevi Genomic Medicine, Inc.

Aevi Genomic Medicine to Host Conference Call to Announce First Quarter and Discuss Recent Business Updates

PHILADELPHIA, PA--(Marketwired - May 3, 2017) - Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today it will host a conference call and live audio webcast on Wednesday, May 10,...
April 27, 2017 08:00 ET | Source: Aevi Genomic Medicine, Inc.

Aevi Genomic Medicine to Present at the 42nd Annual Deutsche Bank Health Care Conference

PHILADELPHIA, PA--(Marketwired - Apr 27, 2017) - Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola, President and Chief Executive Officer, will present...
April 20, 2017 16:30 ET | Source: Aevi Genomic Medicine, Inc.

Aevi Genomic Medicine Presents Updated Results from SAGA Trial of AEVI-001 at the 6th World Congress on ADHD

PHILADELPHIA, PA--(Marketwired - Apr 20, 2017) - -- Novel genetic mutations predictive of response to AEVI-001 found in approximately 10% of pediatric ADHD patients -- -- New...
April 12, 2017 16:30 ET | Source: Aevi Genomic Medicine, Inc.

Aevi Genomic Medicine to Present Updated Results from SAGA Trial of AEVI-001 at the 6th World Congress on ADHD

PHILADELPHIA, PA--(Marketwired - Apr 12, 2017) - Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) today announced that results identifying a genomic subset of responders from the SAGA trial...
March 30, 2017 08:00 ET | Source: Aevi Genomic Medicine, Inc.

Aevi Genomic Medicine to Present at the 16th Annual Needham Healthcare Conference

PHILADELPHIA, PA--(Marketwired - Mar 30, 2017) - Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Brian D. Piper, Chief Financial Officer, will present at the 16th...
March 20, 2017 07:00 ET | Source: Aevi Genomic Medicine, Inc.

Aevi Genomic Medicine Provides Top-line Results from the SAGA Trial of AEVI-001

PHILADELPHIA, PA--(Marketwired - Mar 20, 2017) - Trial did not meet primary endpoint (overall ADHD-RS), however showed encouraging trend in improvement at highest dose...
March 15, 2017 08:00 ET | Source: Aevi Genomic Medicine, Inc.

Aevi Genomic Medicine to Present at the Oppenheimer 27th Annual Healthcare Conference

PHILADELPHIA, PA--(Marketwired - Mar 15, 2017) - Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola, President and Chief Executive Officer, will present...
March 09, 2017 07:30 ET | Source: Aevi Genomic Medicine, Inc.

Aevi Genomic Medicine Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business Update

PHILADELPHIA, PA--(Marketwired - Mar 9, 2017) - Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) Top-line data from SAGA Phase 2/3 trial of AEVI-001 in adolescents with mGluR+ ADHD to be...
February 27, 2017 08:00 ET | Source: Aevi Genomic Medicine, Inc.

Aevi Genomic Medicine to Present at the Cowen and Company 37th Annual Health Care Conference

PHILADELPHIA, PA--(Marketwired - Feb 27, 2017) - Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola, President and Chief Executive Officer, will present...